跳至主要內容
TradingPilot
績效
佈景主題
登入

新聞與行事曆

新聞: 截至 2026-10-09
這些標記是什麼意思

重要性是模型對已發布報導給出的 1–5 分，不是對市場的預測。

已排定事件列上的影響是公司顯著度層級（高/中由圖譜中心度與規模判定；低僅用於人工整理的次要事件），不是對波動幅度的預測。

標記為已確認的財報日期，是 Yahoo Finance 認定由公司確認的；預估表示尚未公布。未加標記的列沒有可查的出處記錄。

經濟數據發布屬於總體經濟、不歸屬任何產業，因此在任何檢視下都會保留。沒有數值的發布表示尚未公布，頁面會直說，而不是顯示為零。

涵蓋被追蹤公司的即將到來的事件；已過去的事件會歸檔，並在可得時補上結果——這些結果都經人工整理並附引用，絕不杜撰。沒有結果的歷史列會顯示「結果待定」。

閉鎖期屆滿或指數調整的列會多出一行算術——將變得可賣出的股數，或指數基金必須買進的股數，以佔流通股的比例表示——依招股說明書或指數編製方法讀出，兩個數字都在該列註明出處。它陳述的是機制，不是價格走勢。由 IPO + 180 天推算出的閉鎖期日期會一直標為預估，直到公司自己說明為止。

未來

已排定 · 今天與明天 · 行事曆更新於 2026-10-12

10月12日週一 · 今天

10月13日週二

過往

已發布 · 最新在前

8月17日週一

產品

11:00
GlobeNewswire

EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU 2.7mg in Wet AMD

EyePoint released topline Phase 3 LUGANO data for DURAVYU (vorolanib intravitreal insert) in wet AMD. Per the release, "The primary endpoint of change from baseline in best corrected visual acuity (BCVA) versus 2 mg aflibercept on-label control was not achieved in the full dataset." The release adds that DURAVYU "was non-inferior to on-label aflibercept (nominal p-value = 0.0096) in an ad hoc analysis excluding a 4% asymmetric cohort (9 of 211 patients) who experienced vision loss (>= 15 letters) unrelated to wet AMD," and reports a 42% reduction in treatment burden versus aflibercept (p-value <0.0001). The on-label 2 mg aflibercept comparator is Regeneron's Eylea; a missed head-to-head primary endpoint by the leading long-duration challenger is relevant to Regeneron's anti-VEGF franchise.

大盤 開啟原文 ↗

產品

11:00
GlobeNewswire

Kratos and GE Aerospace's GEK800 wins USAF EMD contract as second-source JASSM engine, gets F143-ZZ-100 designation

Kratos Defense & Security Solutions and GE Aerospace announced that the GEK800 engine, which received the U.S. Military Engine Type Designation F143-ZZ-100, has been awarded a contract with the United States Air Force for the Engineering, Manufacturing and Development (EMD) of the turbofan as a second-source propulsion system for the Joint Air-to-Surface Standoff Missile (JASSM). The release states Kratos and GE Aerospace began working together in 2023 to complete a Technology Maturation and Risk Reduction (TMRR) phase including testing of the engine.

大盤 開啟原文 ↗

合作

00:00
RTX

RTX's Raytheon awarded seven-year contract for Tomahawk cruise missiles

Raytheon, an RTX business, will accelerate production of Tomahawk cruise missiles for the U.S. Navy under a $22.9 billion seven-year contract awarded as part of the Department of War's Arsenal of Freedom, supporting an annual production ramp to more than 1,000 missiles.

大盤 開啟原文 ↗

合作

00:00
NASA

NASA on-ramps Firefly Aerospace and L3Harris to $100 million Spacecraft Processing Operations Contract

NASA selected All Points Logistics LLC, Blue Origin LLC, Firefly Aerospace and L3Harris Technologies Inc. under the on-ramp provision of its Spacecraft Processing Operations Contract. The contract has a ceiling value of $100 million and a period of performance through February 1, 2033, and covers the facilities and services required to perform prelaunch processing of spacecraft and associated rocket hardware for delivery to the launch pad. The on-ramp lets these vendors furnish commercial payload processing for agency missions launching from locations where such capability was not available at the time of the initial award.

大盤 開啟原文 ↗

8月16日週日

產品

01:15
GlobeNewswire

HII's Newport News Shipbuilding completes acceptance sea trials of carrier John F. Kennedy (CVN 79)

HII's Newport News Shipbuilding division completed acceptance sea trials of John F. Kennedy (CVN 79), the second Gerald R. Ford-class nuclear-powered aircraft carrier. HII said that with the successful completion of acceptance trials, the next step for the ship is preliminary acceptance, which will enable the Navy to begin underway test and evaluation of Kennedy's unique systems. Builder's sea trials had been completed earlier in 2026.

大盤 開啟原文 ↗

原始消息流

所有到達的消息 · 7 天